The influenza vaccine market of India is estimated to reach an approximately value of US$ 155 Million by 2020. The Indian Influenza vaccines market is displaying an impressive growth due to a host of advantages that Influenza vaccine presents. RNCOS new research report entitled, “Indian Influenza Market By Product Type (Vaxigrip, Influvac)-Forecast 2020”, predicts that the increasing potential in the influenza vaccines industry is attributed to constantly rising incidences of Influenza in India. Also, Influenza vaccines, which were earlier neglected, are now being seen as a source of steady income. Various large international and domestic companies, such as Sanofi, Abbott, and Zydus Cadila amongst others are manufacturing and marketing vaccines for the prevention of influenza in India. Apart from these, many other companies, such as Cipla, have also entered this industry owing to large untapped market potential.

In addition to this, factors such as large pool of scientific talent, relatively lower costs in manufacturing, research and development capacity, lower costs of clinical trials, and a high potential for contract services by influenza vaccine manufacturers, will definitely lead to the growth of the Indian Influenza market in the coming years.

Research Analysis and Highlights

The report is dispersed across over 90 pages and provides an in-depth research and rational analysis of the current status and future prospects of the Indian influenza industry. The report also provides a clear picture of the factors driving the industry growth and challenges faced by the industry followed by emerging trends. Additionally, the report includes the study of opportunities, which are available in the Indian influenza market. The report further highlights market in terms of volumes in doses, and value in US$ for the period from 2015 through to 2020. The report also provides detailed bifurcation of Indian influenza market on the basis of product type, such as Vaxigrip, Influvac, and others. In addition, the report provides the potential market for influenza vaccines. Moreover, the report highlights the mergers and acquisitions that have taken place in the Indian influenza market. With special focus on competitive landscape and key players in the market, the research provides valuable information to the investors and debut makers who are looking forward to enter in this market.

Some of the salient features of the report include:

• Innovative technologies aiding Influenza vaccine production
• Partnerships enhancing the development of influenza vaccines
• Increasing government initiatives for influenza vaccination coverage
• Pricing analysis, distribution and supply chain analysis

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM895.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.